Therefore, we performed this meta-analysis about MMP1, 2, 9 and 13 polymorphisms and lung cancer risk by a comprehensive strategy, including logistic regression and model-free approach32, 33, to avoid erroneous model specification and multiple model tests with the risk of an inflated Type I error rate. The gene discussed is MMP1; the disease is lung cancer.